Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors (NCT05427396) | Shanghai Junshi Bioscience Co., Ltd. | 2022-07-28 |
Track Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.